// App-Quantinova.ai

e23246 : PIK3CA mutation analysis in Chinese patients with solid tumors.

Researchers

Presenter

  • Ling Xu

Principal Investigators

  • Xiujuan Qu

  • Rui Ma

  • Yuee Teng

  • Jingdong Zhang

  • Bo Jin

  • Mingfang Zhao

  • Zhi Li

  • Tianshu Guo

  • Zichang Yang

  • Yunpeng Liu

Medical Centers

  • Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  • Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final